Global Canine Arthritis Market - Segmented by Treatment, and Geography - Growth, Trends, and Forecast (2022 - 2030)
The Canine Arthritis Market is expected to register a growth rate of approximately 5.42% during the forecast period, 2018-2023. Canine Arthritis refers to a degenerative joint disease in dogs characterized by inflammation of joints, having symptoms such as limping, stiffness in movement, hunched back posture, aggression, anxiety, and change in appetite, difficulty in walking and jumping. Although it can affect cats and dogs both, it is more prevalent in dogs. Apropos the data by Journal of Scientific Reports in April 2017, the prevalence of osteoarthritis in dogs has been estimated to be approximately 20% based on referral data in the UK dog population. Additional, the journal also states that age-specific prevalence of the disease is around 20% in dogs older than one year while it has been approximated to be 80% in dogs older than eight years, based on radiographic and clinical data from North American canine population.
Rise in Prevalence of Canine Obesity to Propel the Canine Arthritis Market
High prevalence of obesity among the pet population is expected to propel the market growth owing to the direct association of obesity and over-weight with osteoarthritis in dogs. Excess fat and bodyweight increase the load on joint resulting in progression of arthritis and further difficulty in movement. Hence, the prevalence of joint inflammatory diseases is expected to grow with the rise in prevalence of obesity which has currently been identified as the most common nutritional health problem in dogs.
According to the results of 2017 Pet Obesity Survey done by the Association for Pet Obesity Prevention (APOP), 56% of dogs have been identified as overweight (body condition score (BCS) 6-7) or obese (BCS 8-9). Hence, the prevalence of obesity has been observed to be increased, owing to the fact that in 2016, APOP classified 54% of dogs as overweight or obese in the U.S. Similarly, American Animal Hospital Association (AAHA) has estimated 40% to 50% of dogs to be overweight and 25% of dogs to be obese in 2017. Thus the increasing percentage of obese dogs is expected to drive the growth of canine arthritis market.
In addition to the aforementioned factor, the high prevalence of traumatic injuries, genetic disorders, vitamin deficiency among dogs and rise in awareness about companion animal health are expected to propel the market growth over the forecast period.
Side Effects Associated with the Treatment to Limit Growth of the Canine Arthritis Market
The side effects associated with various dietary supplements used to cure canine arthritis are expected to restrain the market growth. Glucosamine and chondroitin are two of the significant components of cartilage that are naturally produced inside the body, and most of the joint supplements contain these two components which sometimes can cause adverse reactions in dogs such as diarrhea, vomiting, and change in blood glucose levels. Similarly, products containing non-steroidal anti-inflammatory drugs (NSAIDs) such as Carprofen can cause gastrointestinal ulcers, pancreatitis, melena, impaired kidney function and liver dysfunction. Long-term use of steroids also decreases joint function and increases the chance of cancer. As a result of these mild as well as severe side effects caused by the drugs used for canine arthritis treatment, the reluctance of pet owners to put their pet animals under medication is expected to restrain the canine arthritis market. Hence, impeding the market growth.
North America to Dominate the Canine Arthritis Market
North America is expected to dominate the canine arthritis market over the forecast period owing to the growing companion animal adoption, and increasing per capita animal healthcare expenditure. In addition, the rise in prevalence of canine obesity, traumatic injuries, genetic disorders such as hip dysplasia, high awareness about pet health among the pet owners, and increase in number of therapies and drugs for the treatment of the disease are some other factors for propelling the growth of the Canine Arthritis in North America.
North America is expected to be followed by Europe being the second largest market for canine arthritis, while Asia-Pacific is expected to demonstrate highest growth rate is owing to the high incidence of vitamin deficiency, metabolic disorders, bacterial infection, gout in dogs and the increase in awareness about various health issues responsible for osteoarthritis. Hence, the aforementioned factors are expected to fuel the growth of the canine arthritis market in the Asia Pacific.
Key Developments in the Market
• Mar 2016 – The U.S. Food and Drug Administration (US FDA) announces the approval of Galliprant, a new drug for controlling pain and inflammation associated with canine arthritis.
• Jul 2018 – CBD DOG Health announces the launch of new products containing healing cannabinoids that can be used to treat joint pain.
Major Players - B NATURALS, BOEHRINGER INGELHEIM, K9 NUTRA, LIQUID HEALTH, INC., LUITPOLD PHARMACEUTICALS, INC., MATSUN NUTRITION, SYNFLEX AMERICA INC., THORNE RESEARCH, INC., VET PRODUCTS DIRECT, and VETALOGICA, among others.
Reasons to Purchase the Report
• The current and future outlook of the global surgical microscopes market in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the market estimate sheet (in Excel)
Customization of the report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
Rise in Prevalence of Canine Obesity to Propel the Canine Arthritis Market
High prevalence of obesity among the pet population is expected to propel the market growth owing to the direct association of obesity and over-weight with osteoarthritis in dogs. Excess fat and bodyweight increase the load on joint resulting in progression of arthritis and further difficulty in movement. Hence, the prevalence of joint inflammatory diseases is expected to grow with the rise in prevalence of obesity which has currently been identified as the most common nutritional health problem in dogs.
According to the results of 2017 Pet Obesity Survey done by the Association for Pet Obesity Prevention (APOP), 56% of dogs have been identified as overweight (body condition score (BCS) 6-7) or obese (BCS 8-9). Hence, the prevalence of obesity has been observed to be increased, owing to the fact that in 2016, APOP classified 54% of dogs as overweight or obese in the U.S. Similarly, American Animal Hospital Association (AAHA) has estimated 40% to 50% of dogs to be overweight and 25% of dogs to be obese in 2017. Thus the increasing percentage of obese dogs is expected to drive the growth of canine arthritis market.
In addition to the aforementioned factor, the high prevalence of traumatic injuries, genetic disorders, vitamin deficiency among dogs and rise in awareness about companion animal health are expected to propel the market growth over the forecast period.
Side Effects Associated with the Treatment to Limit Growth of the Canine Arthritis Market
The side effects associated with various dietary supplements used to cure canine arthritis are expected to restrain the market growth. Glucosamine and chondroitin are two of the significant components of cartilage that are naturally produced inside the body, and most of the joint supplements contain these two components which sometimes can cause adverse reactions in dogs such as diarrhea, vomiting, and change in blood glucose levels. Similarly, products containing non-steroidal anti-inflammatory drugs (NSAIDs) such as Carprofen can cause gastrointestinal ulcers, pancreatitis, melena, impaired kidney function and liver dysfunction. Long-term use of steroids also decreases joint function and increases the chance of cancer. As a result of these mild as well as severe side effects caused by the drugs used for canine arthritis treatment, the reluctance of pet owners to put their pet animals under medication is expected to restrain the canine arthritis market. Hence, impeding the market growth.
North America to Dominate the Canine Arthritis Market
North America is expected to dominate the canine arthritis market over the forecast period owing to the growing companion animal adoption, and increasing per capita animal healthcare expenditure. In addition, the rise in prevalence of canine obesity, traumatic injuries, genetic disorders such as hip dysplasia, high awareness about pet health among the pet owners, and increase in number of therapies and drugs for the treatment of the disease are some other factors for propelling the growth of the Canine Arthritis in North America.
North America is expected to be followed by Europe being the second largest market for canine arthritis, while Asia-Pacific is expected to demonstrate highest growth rate is owing to the high incidence of vitamin deficiency, metabolic disorders, bacterial infection, gout in dogs and the increase in awareness about various health issues responsible for osteoarthritis. Hence, the aforementioned factors are expected to fuel the growth of the canine arthritis market in the Asia Pacific.
Key Developments in the Market
• Mar 2016 – The U.S. Food and Drug Administration (US FDA) announces the approval of Galliprant, a new drug for controlling pain and inflammation associated with canine arthritis.
• Jul 2018 – CBD DOG Health announces the launch of new products containing healing cannabinoids that can be used to treat joint pain.
Major Players - B NATURALS, BOEHRINGER INGELHEIM, K9 NUTRA, LIQUID HEALTH, INC., LUITPOLD PHARMACEUTICALS, INC., MATSUN NUTRITION, SYNFLEX AMERICA INC., THORNE RESEARCH, INC., VET PRODUCTS DIRECT, and VETALOGICA, among others.
Reasons to Purchase the Report
• The current and future outlook of the global surgical microscopes market in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the market estimate sheet (in Excel)
Customization of the report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
